Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 27 390 30 578 31 904 34 120 36 551 39 085
EBITDA 7 022 9 833 - 8 999 9 950 10 386
Operating profit (EBIT) 5 976 6 555 7 110 7 754 8 553 9 369
Pre-Tax Profit (EBT) 2 231 2 873 4 077 4 848 - -
Net income 353 2 334 3 687 4 460 5 538 7 430
P/E ratio 285x 55,2x 42,2x 33,5x 27,3x 22,7x
EPS ( $ ) 0,20 1,31 2,06 2,52 3,10 3,73
Dividend per Share ( $ ) 1,08 1,16 1,32 1,40 1,54 1,71
Yield 1,88% 1,60% 1,52% 1,65% 1,82% 2,02%
Reference price ( $ ) 57,070 72,330 86,860 84,630 84,630 84,630
Announcement Date 01/24/2018
12:45pm
01/23/2019
12:45pm
01/22/2020
12:30pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2020 (e) 2021 (e) 2022 (e)
Debt 18 314 15 480 10 170 5 535 8 626
Finance - - - - -
Operating income (EBITDA) 7 022 9 833 8 999 9 950 10 386
Leverage
(Debt/EBITDA)
2,61x 1,57x 1,13x 0,56x 0,83x
Capital Expenditure 1 000 1 394 1 739 1 869 1 941
Free Cash Flow (FCF) 4 435 4 906 6 151 7 080 7 683
Book Value Per Share (BVPS) ( $ ) 17,7 17,4 23,4 25,0 16,4
Cash Flow per Share ( $ ) 3,18 3,56 4,57 - -
Announcement Date 01/24/2018
12:45pm
01/23/2019
12:45pm
- - -
Balance Sheet Analysis
Assessed data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 154 212 M $ -
Entreprise Value (EV) 164 383 M $ 159 748 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 33,5x 27,3x
Capitalization / Revenue 4,52x 4,22x
EV / Revenue 4,82x 4,50x
EV / EBITDA 18,3x 16,5x
Yield (DPS / Price) 1,65% 1,82%
Price to book (Price / BVPS) 3,61x 3,38x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 22,7% 23,4%
Operating Leverage (Delta EBIT / Delta Sales) 1,31x 1,45x
Net Margin (Net Profit / Revenue) 13,1% 15,2%
ROA (Net Profit / Asset) 8,09% 10,8%
ROE (Net Profit / Equities) 16,2% 17,7%
Rate of Dividend 55,3% 49,7%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   5,10% 5,11%
Cash Flow / Sales 23,6% -
Capital Intensity (Assets / Sales) 1,62x 1,41x
Financial Leverage (Net Debt / EBITDA) 1,13x 0,56x
EPS & Dividend